Tag
Rajeev Juneja
2 articles
Mankind Pharma Q2 FY27 Net Profit Surges 38% YoY
Mankind Pharma reported Q2 FY27 revenue of ₹4,338 Cr, up 17.3% YoY, with EBITDA margins expanding 210 bps to 27.1%.
Net profit grew 37.7% YoY to ₹716 Cr, driven by strong 15.9% growth in domestic busi
Mankind Pharma Q2 Revenue Up 17%, PAT Jumps 38%
Mankind Pharma reported Q2 FY27 revenue growth of 17.3% YoY to INR 4,338 Cr, with EBITDA up 27.2% and PAT surging 37.7%.
Domestic business (ex-consumer healthcare) grew 15.9% YoY, outperforming the IP